Novo Nordisk (NYSE: NVO) Stock Price Trades At Steep Discount As Interim Dividend Confirms 65% Undervaluation Case

Novo Nordisk (NYSE: NVO) Stock Price Trades At Steep Discount As Interim Dividend Confirms 65% Undervaluation Case

Novo Nordisk (NYSE: NVO) has confirmed an interim cash dividend of DKK 3.75 per share for 2026, with the stock going ex-dividend on August 14. The dividend announcement arrives as the Danish pharmaceutical giant faces a challenging stretch, with shares down 10.8% over the past month alone. The one-year total shareholder return has also declined 5.3%, signaling fading momentum despite the continued global focus on obesity and diabetes treatments.…